World Health Organization. Global oral health status report: towards universal health coverage for oral health by 2030. 2022; http://apps.who.int/bookorders.
Tajmirriahi N, Razavi SM, Shirani S, Homayooni S, Gasemzadeh G. Dental Research Journal Evaluation of metastasis and 5-year survival in oral squamous cell carcinoma patients in Isfahan (2001–2015). Dent Res J (Isfahan). 2019;16:117–21.
Gupta S, Kumar P, Das BC. HPV + ve/–ve oral-tongue cancer stem cells: a potential target for relapse-free therapy. Transl Oncol. 2021;14:100919.
Article CAS PubMed Google Scholar
Elaiwy O, El Ansari W, AlKhalil M, Ammar A. Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: retrospective study of 154 cases over 7 years in Qatar. Ann Med Surg (London). 2020;60:195–200.
Wang B, Zhang S, Yue K, Wang XD. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013;32:614–8.
Article PubMed PubMed Central Google Scholar
Bodner L, Manor E, Friger MD, Van Der Waal I. Oral squamous cell carcinoma in patients twenty years of age or younger - review and analysis of 186 reported cases. Oral Oncol. 2014;50:84–9.
Nicoletti G, Soutar DS, Jackson MS, Wrench AA, Robertson G. Chewing and swallowing after surgical treatment for oral cancer: functional evaluation in 196 selected cases. Plast Reconstr Surg. 2004;114:329–38.
Son YR, Choi KH, Kim TG. Dysphagia in tongue cancer patients. Ann Rehabil Med. 2015;39:210–7.
Article PubMed PubMed Central Google Scholar
Azari F, Kennedy G, Bernstein E, Hadjipanayis C, Vahrmeijer AL, Smith BL et al. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt. 2021;26.
Pan J, Deng H, Hu S, Xia C, Chen Y, Wang J, et al. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC. World J Surg Oncol. 2020;18:96.
Article PubMed PubMed Central Google Scholar
Cortese S, Kerrien E, Yakavets I, Meilender R, Mastronicola R, Renard S et al. ICG-induced NIR fluorescence mapping in patients with head & neck tumors after the previous radiotherapy. Photodiagnosis Photodyn Ther. 2020;31.
Gao RW, Teraphongphom NT, van den Berg NS, Martin BA, Oberhelman NJ, Divi V, et al. Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence. Cancer Res. 2018;78:5144–54.
Article CAS PubMed PubMed Central Google Scholar
van Keulen S, Nishio N, Fakurnejad S, van den Berg NS, Lu G, Birkeland A, et al. Intraoperative Tumor Assessment Using Real-Time Molecular Imaging in Head and Neck Cancer patients. J Am Coll Surg. 2019;229:560–e5671.
Rehmani HS, Issaeva N. EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations. Ann Transl Med. 2020;8:813–813.
Article PubMed PubMed Central Google Scholar
De Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, De Jong JS et al. In vivo fluorescence immunohistochemistry: localization of fluorescently labeled Cetuximab in squamous cell carcinomas. Sci Rep. 2015;5.
Rosenthal EL, Warram JM, De Boer E, Chung TK, Korb ML, Brandwein-Gensler M, et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin Cancer Res. 2015;21:3658–66.
Article CAS PubMed PubMed Central Google Scholar
Marsico G, Russo L, Quondamatteo F, Pandit A. Glycosylation and integrin regulation in Cancer. Trends Cancer Cell Press. 2018;4(8):537–52.
Ahmedah HT, Patterson LH, Shnyder SD, Sheldrake HM. RGD-binding integrins in head and neck cancers. Cancers (Basel). MDPI AG; 2017.
Su CY, Li JQ, Zhang LL, Wang H, Wang FH, Tao YW, et al. The Biological functions and clinical applications of integrins in cancers. Front Pharmacol. Frontiers Media S.A.; 2020.
Li HX, Zheng JH, Fan HX, Li HP, Gao ZX, Chen D. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: Association with clinical outcomes and prognostic implications. J Oral Pathol Med. 2013;42:547–56.
Article CAS PubMed Google Scholar
Thomas GJ, Nyström ML, Marshall JF. αvβ6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med. 2006;35:1–10.
Article CAS PubMed Google Scholar
Baart VM, van Duijn C, van Egmond SL, Dijckmeester WA, Jansen JC, Vahrmeijer AL, et al. Egfr and αvβ6 as promising targets for molecular imaging of cutaneous and mucosal squamous cell carcinoma of the head and neck region. Cancers (Basel). 2020;12:1474.
Article CAS PubMed Google Scholar
Xue H, Atakilit A, Zhu W, Li X, Ramos DM, Pytela R. Role of the αvβ6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun. 2001;288:610–8.
Article CAS PubMed Google Scholar
Khan Z, Marshall JF. The role of integrins in TGFβ activation in the tumour stroma. Cell Tissue Res Springer Verlag. 2016;365:657–73.
Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol. 2011;223:470–81.
Article CAS PubMed Google Scholar
Kapp TG, Rechenmacher F, Neubauer S, Maltsev OV, Cavalcanti-Adam EA, Zarka R et al. A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins. Sci Rep. 2017;7.
Cardle II, Jensen MC, Pun SH, Sellers DL. Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting. J Biol Chem. 2021;296:100657.
Article CAS PubMed PubMed Central Google Scholar
Hausner SH, DiCara D, Marik J, Marshall JF, Sutcliffe JL. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin αvβ6 expression with positron emission tomography. Cancer Res. 2007;67:7833–40.
Article CAS PubMed Google Scholar
Meecham A, Marshall J. Harnessing the power of foot-and-mouth-disease virus for targeting integrin alpha-v beta-6 for the therapy of cancer. Volume 16. Expert Opin Drug Discov. Taylor and Francis Ltd.; 2021. pp. 737–44. 7.
Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, et al. Targeted in vivo imaging of integrin αvβ6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009;69:5843–50.
Article CAS PubMed PubMed Central Google Scholar
Ganguly T, Tang SY, Bauer N, Sutcliffe JL. Evaluation of two Optical Probes for Imaging the integrin αvβ6 – in Vitro and in vivo in Tumor-Bearing mice. Mol Imaging Biol. 2020;22:1170–81.
Article CAS PubMed Google Scholar
Tosca EM, Ronchi D, Facciolo D, Magni P. Replacement, reduction, and refinement of animal experiments in Anticancer Drug Development: the contribution of 3D in Vitro Cancer models in the drug Efficacy Assessment. Biomedicines. 2023;11(4):1058.
Article CAS PubMed PubMed Central Google Scholar
Hockney S, Parker J, Turner JE, Todd X, Todryk S, Gieling RG, et al. Next generation organoid engineering to replace animals in cancer drug testing. Biochem Pharmacol. Elsevier Inc.; 2023.
Francois A, Dirheimer L, Chateau A, Lassalle HP, Bezdetnaya L, Yakavets I. A macrophages-enriched Head and Neck Tumor Spheroid Model to Study Foslip® Behavior in Tumor Microenvironment. Int J Nanomed. 2023;18:6545–62.
Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T. In Vitro models of Head and Neck Cancer: from primitive to most Advanced. J Pers Med. 2023;13:1575.
Article PubMed PubMed Central Google Scholar
Liu C, Mak M. Fibroblast-mediated uncaging of cancer cells and dynamic evolution of the physical microenvironment. Sci Rep. 2022;12.
Qian L-W, Mizumoto K, Maehara N, Ohuchida K, Inadome N, Saimura M et al. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production [Internet]. www.elsevier.com/locate/canlet.
Lee C, Lee C, Atakilit A, Siu A. M.Ramos D. Differential spheroid formation by oral cancer cells. Anticancer Res. 2014;34:6945–9.
Andreiuk B, Reisch A, Lindecker M, Follain G, Peyriéras N, Goetz JG et al. Fluorescent polymer nanoparticles for cell barcoding in Vitro and in vivo. Small. 2017;13.
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating Tumor Subgroup Gene expression and survival analyses. Neoplasia. 2017;19:649–58.
Comments (0)